Burkly Linda's Form 4 filing
Editas Medicine, Inc. (EDIT) · filed Jul 26, 2024
- Accession no.
- 0001650664-24-000090
- Filed
- Jul 26, 2024
- Trade date
- Jul 25, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $64.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burkly LindaCIK 0001985604 | Officer (EVP, CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2024 | Common Stock | SSaleDisposed | −11,886 | $5.42 | −$64,422.12 | 73,136 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.